Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04FTB
|
|||
| Former ID |
DIB009398
|
|||
| Drug Name |
AR-H049020
|
|||
| Indication | Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Discontinued in Phase 1 | [1] | |
| Company |
AstraZeneca plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016001) | |||
| REF 2 | CN patent application no. 100577175, Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.